A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia

Current Medical Research and Opinion

Volumn 24, Issue 10, 2008, Pages 2931-2942

  Mel, J R ^a   Salar, A ^b   Rodriguez C A ^c   Alegre, A ^d   Gonzalez A ^e   Cassinello, J ^f   Montesinos, J ^g   Gasquet, J A ^h   Sanchez J ^h   Saigí, Eugeni ^h   Roig, I ⁱ   Soler, J A ⁱ   Bermejo, J C ^j   Palacios, A ^k   Gallur, L ^k   Mayor, J Fabregat ^b   Mora, M A Cruz ^l   Aliguer, M Nogué ^m   Centelles, M ^j   Hernandez F ⁿ   de Tarranco, A Velasco Ortiz ^d   Lanza, A Arcusa ^o   Allege, Ma J ^p   Gurpide A ^q   Morales, I Español ^r   Choupana Gil Casares, J L Bello ^s   Pinto, M García ^o   Barón, M González ⁿ   Benet, J Orriols ^t   Batista, N ^a   Gonzalez M A ^u   Rubio, J Casal ^v   Váquez, M Ramos ^w   Marco, J García ^x   Malaver, D Hernández ^y   more..

^a HOSPITAL XERAL CALDE   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e C O Galicia J A Quiroga Piñero   (Spain)

^f HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^g Servicio de Oncología Médica   (Spain)

^h Amgen SA   (Spain)

ⁱ Department of Pediatrics   (Spain)

^j HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

^k HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^l HOSPITAL VIRGEN DE LA SALUD   (Spain)

^m HOSPITAL GENERAL DE VIC   (Spain)

ⁿ HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^o Hospital Sagrado Corazón ^*  (Spain)

^p Departamento de Neurología   (Spain)

^q UNIVERSITY CLINIC OF NAVARRA   (Spain)

^r Hospital Cruz Roja   (Spain)

^s HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^t Hospital Clínico Universitario de las Canarias   (Spain)

^u HOSPITAL DO MEIXOEIRO   (Spain)

^v Hospital La Paz ^*  (Spain)

^w HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^x D Hernández Malaver   (Spain)

^y MD ANDERSON CANCER CENTER   (Spain)

more..

Author keywords

Anaemia; Darbepoetin alfa; Fatigue; Multi cycle chemotherapy

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLATINUM; PREDNISOLONE; TAXANE DERIVATIVE; VINCRISTINE SULFATE;

ABDOMINAL PAIN; ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; ASTHENIA; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL PRACTICE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIARRHEA; DRUG APPROVAL; DRUG EFFICACY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FEVER; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSOMNIA; KARNOFSKY PERFORMANCE STATUS; LUNG EMBOLISM; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MUCOSA INFLAMMATION; MULTICENTER STUDY; NAUSEA; NEUTROPENIA; OBSERVATIONAL STUDY; PAIN; PARESTHESIA; PROSPECTIVE STUDY; SCORING SYSTEM; SOLID TUMOR; THROMBOCYTOSIS; TREATMENT DURATION; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ANTINEOPLASTIC AGENTS; ERYTHROPOIESIS; ERYTHROPOIETIN; FATIGUE; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; TIME FACTORS;

EID: 55549095665     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007990802381323     Document Type: Article

References (10)

1. Ludwig H, Van Belle S, Barrett-Lee P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence and treatment of anaemia in cancer patients. Eur J Cancer 2004;40: 2293-306
2. Nowrousian MR. Pathophysiology of cancer-related anemia. In: Smyth JF, Boogaerts MA, Ehmer BRM, editors. Rh-erythropoietin in cancer supportive treatment. New York: Marcel Dekker; 1996. p. 13-34
3. Caro JJ, Salas M, Ward A, et al. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 2001;91:2214-21
4. Ludwig H, Strasser K. Symptomatology of anemia. Semin Oncol 2001;28(2 Suppl 8):7-14
5. Demetri GD. Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy. Br J Cancer 2001;84:31-7
6. Crawford J, Cella D, Cleeland C, et al. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer 2002;195:888-95
7. Gabrilove J, Cleeland C, Livingston R, et al. Clinical evaluation of once weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol 2001;19:2875-82
8. Glaspy J, Jadeja J, Justice G, et al. Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy. Br J Cancer 2002;87:268-76
9. Littlewood T, Bajetta E, Nortier JWR, et al. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001;19:2865-74
10. Cella D, Kallich J, McDermott A, et al. The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials. Ann Oncol 2004;15:979-86